- Home
- MYO vs SEER Comparison
MYO vs SEER Comparison
Compare MYO & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYO
- SEER
- Stock Information
- Founded
- MYO 2004
- SEER 2017
- Country
- MYO United States
- SEER United States
- Employees
- MYO N/A
- SEER N/A
- Industry
- MYO Industrial Specialties
- SEER Medicinal Chemicals and Botanical Products
- Sector
- MYO Health Care
- SEER Health Care
- Exchange
- MYO Nasdaq
- SEER Nasdaq
- Market Cap
- MYO 113.3M
- SEER 114.3M
- IPO Year
- MYO 2017
- SEER 2020
- Fundamental
- Price
- MYO $4.78
- SEER $2.38
- Analyst Decision
- MYO Strong Buy
- SEER Hold
- Analyst Count
- MYO 4
- SEER 1
- Target Price
- MYO $7.75
- SEER $3.00
- AVG Volume (30 Days)
- MYO 199.1K
- SEER 291.2K
- Earning Date
- MYO 11-06-2024
- SEER 11-06-2024
- Dividend Yield
- MYO N/A
- SEER N/A
- EPS Growth
- MYO N/A
- SEER N/A
- EPS
- MYO N/A
- SEER N/A
- Revenue
- MYO $25,239,125.00
- SEER $14,608,000.00
- Revenue This Year
- MYO $53.19
- SEER N/A
- Revenue Next Year
- MYO $39.01
- SEER $40.36
- P/E Ratio
- MYO N/A
- SEER N/A
- Revenue Growth
- MYO 36.23
- SEER N/A
- 52 Week Low
- MYO $2.51
- SEER $1.51
- 52 Week High
- MYO $5.64
- SEER $2.50
- Technical
- Relative Strength Index (RSI)
- MYO 60.02
- SEER 66.32
- Support Level
- MYO $4.56
- SEER $2.23
- Resistance Level
- MYO $5.15
- SEER $2.35
- Average True Range (ATR)
- MYO 0.37
- SEER 0.14
- MACD
- MYO 0.03
- SEER 0.01
- Stochastic Oscillator
- MYO 65.87
- SEER 80.00
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.